期刊
JOURNAL OF NUCLEAR MEDICINE
卷 62, 期 9, 页码 1181-1188出版社
SOC NUCLEAR MEDICINE INC
DOI: 10.2967/jnumed.120.256230
关键词
image-guided HIFU; targeted drug delivery; tumor ablation; hyperthermia; PET/MR image guidance
资金
- German Ministry of Science and Technology BMBF project SONO-RAY [03Z1L511]
Image-guided high-intensity focused ultrasound (HIFU) has gained increasing popularity in medicine for tumor ablation, neurological disease treatment, and bone metastases management. The mechanical and thermal effects of focused ultrasound enable tissue histotripsy, supportive radiation therapy, and targeted drug delivery. Integration of imaging modalities into HIFU systems enhances treatment precision and safety, showing potential to reduce adverse effects and improve postoperative quality of life.
Image-guided high-intensity focused ultrasound (HIFU) has been increasingly used in medicine over the past few decades, and several systems for such have become commercially available. HIFU has passed regulatory approval around the world for the ablation of various solid tumors, the treatment of neurologic diseases, and the palliative management of bone metastases. The mechanical and thermal effects of focused ultrasound provide a possibility for histotripsy, supportive radiation therapy, and targeted drug delivery. The integration of imaging modalities into HIFU systems allows for precise temperature monitoring and accurate treatment planning, increasing the safety and efficiency of treatment. Preclinical and clinical results have demonstrated the potential of image-guided HIFU to reduce adverse effects and increase the quality of life postoperatively. Interventional nuclear image-guided HIFU is an attractive noninvasive option for the future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据